Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

被引:84
|
作者
Wei, Chuang [1 ]
Jiang, Zeyu [2 ]
Li, Congcong [1 ]
Li, Peifeng [1 ]
Fu, Qinrui [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Inst Translat Med, Coll Med, Qingdao 266021, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Cardiovasc Med, Qingdao 266021, Peoples R China
基金
中国国家自然科学基金;
关键词
cardiovascular diseases; diagnosis; endogenous biomarkers; nanomaterials; therapy; SMOOTH-MUSCLE-CELLS; VULNERABLE ATHEROSCLEROTIC PLAQUE; ACUTE MYOCARDIAL-INFARCTION; DRUG-DELIVERY SYSTEM; ANTI-PEG ANTIBODIES; OXYGEN SPECIES ROS; PHOTODYNAMIC THERAPY; HEART-FAILURE; IN-VIVO; ADHESION MOLECULE-1;
D O I
10.1002/adfm.202214655
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels the development of advanced technologies for CVD diagnosis and treatment. Biomarker-responsive nanomaterials are appealing therapeutic platforms that provide new horizons for CVD theranostics. In this review, recent advances in nanomaterials with endogenous biomarkers as stimuli or targets for CVD theranostics is presented. First, the categories of biomarkers involved are comprehensively itemized based on pathological mechanisms including pH, reactive oxygen species, lipids, enzymes, macrophage receptors, subendothelium components, platelet receptors, inflammation, and osteopontin. The role of these biomarkers in bridge-building between nanomaterials and CVD is then presented. Next, the biomedical applications of nanomaterials responsive to endogenous biomarkers as stimuli or targets for the diagnosis and treatment of CVD are elaborated. Finally, the challenges and future research directions of biomarker-responsive nanomaterials in CVD are also discussed. This review will provide scientific guidance to facilitate clinical applications of biomarker-responsive nanomaterials.
引用
收藏
页数:42
相关论文
共 50 条
  • [1] Development of endogenous enzyme-responsive nanomaterials for theranostics
    Mu, Jing
    Lin, Jing
    Huang, Peng
    Chen, Xiaoyuan
    CHEMICAL SOCIETY REVIEWS, 2018, 47 (15) : 5554 - 5573
  • [2] Nanomaterials as novel cardiovascular theranostics
    Galvanotechnik, 2021, 112 (06): : 810 - 814
  • [3] Nanomaterials as Novel Cardiovascular Theranostics
    Pala, Rajasekharreddy
    Pattnaik, Subhaswaraj
    Busi, Siddhardha
    Nauli, Surya M.
    PHARMACEUTICS, 2021, 13 (03)
  • [4] Harnessing Endogenous Stimuli for Responsive Materials in Theranostics
    Cook, Alexander B.
    Decuzzi, Paolo
    ACS NANO, 2021, 15 (02) : 2068 - 2098
  • [5] Carbon nanomaterials for cardiovascular theranostics: Promises and challenges
    Alagarsamy, Keshav Narayan
    Mathan, Sajitha
    Yan, Weiang
    Rafieerad, Alireza
    Sekaran, Saravanan
    Manego, Hanna
    Dhingra, Sanjiv
    BIOACTIVE MATERIALS, 2021, 6 (08) : 2261 - 2280
  • [6] External stimulus responsive inorganic nanomaterials for cancer theranostics
    Mohamed, Sheikh M.
    Veeranarayanan, Srivani
    Maekawa, Toru
    Kumar, Sakthi D.
    ADVANCED DRUG DELIVERY REVIEWS, 2019, 138 : 18 - 40
  • [7] Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics
    Liu, Yuying
    Li, Congcong
    Yang, Xiao
    Yang, Bin
    Fu, Qinrui
    BIOMATERIALS SCIENCE, 2024, 12 (15) : 3805 - 3825
  • [8] Nanomedical Theranostics in Cardiovascular Disease
    Tang J.
    Lobatto M.E.
    Read J.C.
    Mieszawska A.J.
    Fayad Z.A.
    Mulder W.J.M.
    Current Cardiovascular Imaging Reports, 2012, 5 (1) : 19 - 25
  • [9] Integrin-Specific Stimuli-Responsive Nanomaterials for Cancer Theranostics
    Taheri, Zahra
    Mozafari, Negin
    Moradian, Ghazal
    Lovison, Denise
    Dehshahri, Ali
    De Marco, Rossella
    PHARMACEUTICS, 2024, 16 (11)
  • [10] Near-infrared light-responsive nanomaterials for cancer theranostics
    Kim, Heejung
    Chung, Kyungwha
    Lee, Seungjin
    Kim, Dong Ha
    Lee, Hyukjin
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (01) : 23 - 45